Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Tissue Engineering Market Research Reports
Tissue Engineering Market Research Reports
| Title | published | price | |
|---|---|---|---|
Polyarticular Juvenile Idiopathic Arthritis (PJIA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... vides an overview of the Polyarticular Juvenile Idiopathic Arthritis (PJIA) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Polyarticular Juvenile Idiopathic Arthritis (PJIA), c......" | 02-May-2022 | $2000 | |
Muscle Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "......
The report provides comprehensive information on the therapeutics under development for Muscle Atrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The repo......" | 02-May-2022 | $2000 | |
Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... eport provides comprehensive information on the therapeutics under development for Muscle Spasm, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also ......" | 02-May-2022 | $2000 | |
Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... br />
The report provides comprehensive information on the therapeutics under development for Myotonic Dystrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecul......" | 02-May-2022 | $2000 | |
Limb-Girdle Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... cular Dystrophy pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Limb-Girdle Muscular Dystrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action ......" | 02-May-2022 | $2000 | |
Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ect pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Articular Cartilage Defect, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of ......" | 02-May-2022 | $2000 | |
Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... e report provides comprehensive information on the therapeutics under development for Bone Fracture, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report a......" | 02-May-2022 | $2000 | |
Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Bone Regeneration, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Ty......" | 02-May-2022 | $2000 | |
Cachexia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... es comprehensive information on the therapeutics under development for Cachexia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descr......" | 02-May-2022 | $2000 | |
Mitochondrial Myopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... landscape.
The report provides comprehensive information on the therapeutics under development for Mitochondrial Myopathy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (......" | 02-May-2022 | $2000 | |
| | |||